(2026). Polypharmacy is associated with lower progression from MCI to Alzheimer's disease, with sex‐specific patterns across drug classes. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Polypharmacy Is Associated with Lower Progression from MCI to Alzheimer's Disease, with Sex‐specific Patterns Across Drug Classes."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Polypharmacy Is Associated with Lower Progression from MCI to Alzheimer's Disease, with Sex‐specific Patterns Across Drug Classes."
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.